Checkpoint Capital
San Francisco, Californiacheckpoint.capital
Overview
Checkpoint Capital is an investment fund that partners with and invests in biopharmaceutical companies that are developing and commercializing new medicines. The firm manages the Checkpoint Capital (Master) Fund LP.
Portfolio Companies
2
Website
checkpoint.capitalInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Diagonal Therapeutics | Jan 2026 | Series B | Co-investor |
| Elektrofi | Oct 2024 | Series C | Co-investor |
| Diagonal Therapeutics | Apr 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.